CJEU adviser to give opinion on SPC term

An adviser at Europe’s highest court is expected to issue an opinion on whether the term of a supplementary protection certificate (SPC) begins once it is authorised or when the applicant has been notified about it.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Video interview: Hogan Lovells discusses implications of Brexit on SPCs

25 August 2016 In an exclusive interview with LSIPR, Stephen Bennett, partner at Hogan Lovells, talks about the implications of Brexit with a focus on supplementary protection certificates.

Biotechnology

SPCs should start once authorisation is broadcast, says AG

10 September 2015 Supplementary protection certificates should take effect once an applicant for marketing authorisation has been notified of the authorisation, an advocate-general has urged the Court of Justice of the European Union to confirm.

More features

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation: Follow the money (Part I)

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Former PTAB judge joins Sterne Kessler

GSK escalates mRNA COVID-19 vaccine dispute

CJEU adviser to give opinion on SPC term

More on this story

Editor's picks

Editor's picks

More features